Toulouse, France

Francis Brion

This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francis Brion. Retrieved from https://idiyas.com/inventor/francis-brion-x4cnfxri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Francis Brion

Introduction

Francis Brion is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Brion has demonstrated his expertise and creativity in developing new compounds.

Latest Patents

Brion's latest patents include groundbreaking work on compounds such as (3,4,7,8,9,10-hexahydro-6,10-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic-acid derivatives and (3,4,7,8,9,10-hexahydro-6,10-dioxo-6H pyridazino [1,2-A] [1,2] diazepine-1-carboxylic acid derivatives. These innovations reflect his commitment to advancing pharmaceutical science.

Career Highlights

Brion is currently associated with Aventis Pharma S.A., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the company’s portfolio but has also had a lasting impact on the industry.

Collaborations

Throughout his career, Brion has collaborated with talented individuals such as Veronique Croco and Patrick Roussel. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Francis Brion's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to inspire advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…